Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Income from Continuing Operations (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Income from Continuing Operations for 6 consecutive years, with 156669.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 1673.46% to 156669.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 719051.0 through Dec 2025, up 726.5% year-over-year, with the annual reading at 642090.0 for FY2025, 638.03% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 156669.0 at BioScience Health Innovations, down from 8782.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 457704.0 in Q2 2025, with the low at 156669.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 21119.7, with a median of 13378.5 recorded in 2021.
  • Peak annual rise in Income from Continuing Operations hit 899.53% in 2025, while the deepest fall reached 1673.46% in 2025.
  • Over 5 years, Income from Continuing Operations stood at 14089.0 in 2021, then plummeted by 105.25% to 28917.0 in 2022, then tumbled by 32.71% to 38376.0 in 2023, then soared by 125.95% to 9957.0 in 2024, then tumbled by 1673.46% to 156669.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 156669.0, 8782.0, and 457704.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.